These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 19022802)
1. A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells. Zuberbühler K; Palumbo A; Bacci C; Giovannoni L; Sommavilla R; Kaspar M; Trachsel E; Neri D Protein Eng Des Sel; 2009 Mar; 22(3):169-74. PubMed ID: 19022802 [TBL] [Abstract][Full Text] [Related]
2. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470 [TBL] [Abstract][Full Text] [Related]
3. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Ferrara C; Brünker P; Suter T; Moser S; Püntener U; Umaña P Biotechnol Bioeng; 2006 Apr; 93(5):851-61. PubMed ID: 16435400 [TBL] [Abstract][Full Text] [Related]
4. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology. Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304 [TBL] [Abstract][Full Text] [Related]
5. [Preparation, purification and identification of the rabbit antibody against extracellular region of mLAIR-1]. Zhang Y; Zhuang R; Jin BQ; Ouyang WM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):595-7. PubMed ID: 16143065 [TBL] [Abstract][Full Text] [Related]
6. High-level expression of full-length antibodies using trans-complementing expression vectors. Bianchi AA; McGrew JT Biotechnol Bioeng; 2003 Nov; 84(4):439-44. PubMed ID: 14574701 [TBL] [Abstract][Full Text] [Related]
7. Application of the Fc fusion format to generate tag-free bi-specific diabodies. Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. Li J; Menzel C; Meier D; Zhang C; Dübel S; Jostock T J Immunol Methods; 2007 Jan; 318(1-2):113-24. PubMed ID: 17161420 [TBL] [Abstract][Full Text] [Related]
9. Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications. Peipp M; Saul D; Barbin K; Bruenke J; Zunino SJ; Niederweis M; Fey GH J Immunol Methods; 2004 Feb; 285(2):265-80. PubMed ID: 14980440 [TBL] [Abstract][Full Text] [Related]
10. Comparative expression of different antibody formats in mammalian cells and Pichia pastoris. Braren I; Greunke K; Umland O; Deckers S; Bredehorst R; Spillner E Biotechnol Appl Biochem; 2007 Aug; 47(Pt 4):205-14. PubMed ID: 17373908 [TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and identification of anti-carbofuran single chain Fv gene. Wang H; Yang J; Liu X; Liang Y; Lei H; Shen Y; Xu X; Sun Y; Xu Z; He Y Biotechnol Prog; 2009; 25(4):1018-24. PubMed ID: 19653307 [TBL] [Abstract][Full Text] [Related]
13. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains. Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019 [TBL] [Abstract][Full Text] [Related]
14. Screening for improved cell performance: selection of subclones with altered production kinetics or improved stability by cell sorting. Böhm E; Voglauer R; Steinfellner W; Kunert R; Borth N; Katinger H Biotechnol Bioeng; 2004 Dec; 88(6):699-706. PubMed ID: 15532061 [TBL] [Abstract][Full Text] [Related]
15. Isolating and engineering human antibodies using yeast surface display. Chao G; Lau WL; Hackel BJ; Sazinsky SL; Lippow SM; Wittrup KD Nat Protoc; 2006; 1(2):755-68. PubMed ID: 17406305 [TBL] [Abstract][Full Text] [Related]
16. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability. Matasci M; Baldi L; Hacker DL; Wurm FM Biotechnol Bioeng; 2011 Sep; 108(9):2141-50. PubMed ID: 21495018 [TBL] [Abstract][Full Text] [Related]
17. A human cDNA library for high-throughput protein expression screening. Büssow K; Nordhoff E; Lübbert C; Lehrach H; Walter G Genomics; 2000 Apr; 65(1):1-8. PubMed ID: 10777659 [TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen. Bose B; Khanna N; Acharya SK; Sinha S J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690 [TBL] [Abstract][Full Text] [Related]
19. Controlled growth of Chinese hamster ovary cells and high expression of antibody-IL-2 fusion proteins by temperature manipulation. Shi M; Xie Z; Yu M; Shen B; Guo N Biotechnol Lett; 2005 Dec; 27(23-24):1879-84. PubMed ID: 16328984 [TBL] [Abstract][Full Text] [Related]
20. Using matrix attachment regions to improve recombinant protein production. Harraghy N; Buceta M; Regamey A; Girod PA; Mermod N Methods Mol Biol; 2012; 801():93-110. PubMed ID: 21987249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]